AntalGenics S.L. is a biotechnological company dedicated to the design and development of innovative active molecules for biomedical and dermocosmetic applications. Their research and development (R&D) program emphasizes the discovery of active compounds that target sensory neurobiology, aiming to enhance both pharmaceutical and cosmetic products. The company has successfully licensed cosmeceutical products and holds patents for new analgesic and cosmetic molecules, showcasing their commitment to translating scientific research into practical applications that improve quality of life.

The company operates with a strong focus on quality, as evidenced by their ISO 9001:2015 certification. AntalGenics acts as an intermediary between the research community and the commercial sector, facilitating the transition of scientific discoveries into market-ready products. Their strategy includes developing internal R&D projects with validated targets, licensing leads post Phase II/III clinical trials, and collaborating with public research to incorporate novel technologies. This approach not only fosters innovation but also allows for tailored R&D projects that can generate intellectual property rights for third parties.

Spain

AntalGenics is a biotechnological company focused on the design and development of new active molecules for biomedical and dermocosmetic applications

MISSION
To discover and develop innovative leads in the field of sensory neurobiology with pharmaceutical and dermocosmetical applications.

VISION
To transform our scientific results into products and services for society and to improve the quality of life.

AntalGenics S.L.

Company Details